Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma
Markus Schick, Le Zhang, Sabine Maurer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis
Xueju Wei, Yue Huo, Jingnan Pi, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 8, pp. 1278-1290
Closed Access | Times Cited: 102
SUMO proteases: from cellular functions to disease
Laura A. Claessens, Alfred C.O. Vertegaal
Trends in Cell Biology (2024) Vol. 34, Iss. 11, pp. 901-912
Closed Access | Times Cited: 19
DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
Yejinpeng Wang, Lingao Ju, Gang Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Immune regulation by the SUMO family
M.D. Neranjan Tharuka, Asimina S. Courelli, Yuan Chen
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 1
SENP6 regulates localization and nuclear condensation of DNA damage response proteins by group deSUMOylation
Laura A. Claessens, Matty Verlaan–de Vries, Ilona J. de Graaf, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
SUMO and the DNA damage response
Jai S. Bhachoo, Alexander J. Garvin
Biochemical Society Transactions (2024) Vol. 52, Iss. 2, pp. 773-792
Open Access | Times Cited: 7
SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer
Wenyan Wu, Chao Huang
Life Sciences (2023) Vol. 332, pp. 122085-122085
Closed Access | Times Cited: 14
SENP6 induces microglial polarization and neuroinflammation through de-SUMOylation of Annexin-A1 after cerebral ischaemia–reperfusion injury
Meng Mao, Qian Xia, Gaofeng Zhan, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases
Nieves Lara-Ureña, Vahid Jafari, Mario García‐Domínguez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8012-8012
Open Access | Times Cited: 19
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
Guus J.J.E. Heynen, Francis Baumgartner, Michael Heider, et al.
Blood Advances (2022) Vol. 7, Iss. 4, pp. 469-481
Open Access | Times Cited: 18
Identification of the SUMOylation Gene Signature in Colon Cancer by Transcriptome and Mendelian Randomization Integration
Xiaobin Zhang, Qingshui Yang, Zongyu Liang, et al.
European Journal of Cancer Care (2025) Vol. 2025, Iss. 1
Open Access
Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma
Ke Lu, Ming Zhang, Hongyu Qin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2977-2991
Open Access | Times Cited: 2
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution
Anja Fischer, Robert Lersch, Niklas de Andrade Krätzig, et al.
Cell Genomics (2023) Vol. 3, Iss. 3, pp. 100276-100276
Open Access | Times Cited: 4
SUMO protease SENP6 protects the nucleus from hyperSUMOylation-induced laminopathy-like alterations
Magda Liczmańska, Michael H. Tatham, Barbara Mojsa, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112960-112960
Open Access | Times Cited: 4
SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8
Jinghui Guo, Hui Zheng, Sidong Xiong
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 8, pp. 892-904
Open Access | Times Cited: 1
The association between cumulative exposure to PM2.5 and DNA methylation measured using methyl-capture sequencing among COPD patients
Hyun Woo Ji, Jieun Kang, Hwan‐Cheol Kim, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Stress combined with loss of the Candida albicans SUMO protease Ulp2 triggers selection of aneuploidy via a two-step process
Marzia Rizzo, Natthapon Soisangwan, Samuel Bernardo Pérez Vega, et al.
PLoS Genetics (2022) Vol. 18, Iss. 12, pp. e1010576-e1010576
Open Access | Times Cited: 6
Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy
Uta M. Demel, Matthias Wirth, Schayan Yousefian, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 555-567
Open Access | Times Cited: 5
Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response
Le Zhang, Matthias Wirth, Upayan Patra, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 9
Open Access | Times Cited: 2
NF-κB c-REL-OTUD4 axis regulates B-cell receptor in B-cell lymphoma
Eslam Katab, Anushree Kumar, Katja Steiger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8
Sidong Xiong, Jinghui Guo, Hui Zheng
Research Square (Research Square) (2023)
Open Access
Lymphdrüsenkrebs: Zentraler Signalweg in der Tumorentstehung aufgeklärt

TumorDiagnostik & Therapie (2022) Vol. 43, Iss. 02, pp. 84-86
Closed Access
Page 1

Scroll to top